GSK3B and neoplasm: It was reported that inhibition of GSK3β decreased the viability of ARMS tumor cells.19 Similarly, we found that treatment of cells with GSK3β inhibitors for extended periods of time (>72 h) resulted in a level of cell death that precluded the use of these inhibitors in our proliferation assay (data not shown).